177 related articles for article (PubMed ID: 22343491)
1. Cyr61 is a potential prognostic marker for prostate cancer.
Terada N; Kulkarni P; Getzenberg RH
Asian J Androl; 2012 May; 14(3):405-8. PubMed ID: 22343491
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment.
D'Antonio KB; Schultz L; Albadine R; Mondul AM; Platz EA; Netto GJ; Getzenberg RH
Clin Cancer Res; 2010 Dec; 16(23):5908-13. PubMed ID: 21138874
[TBL] [Abstract][Full Text] [Related]
3. Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness.
Terada N; Shiraishi T; Zeng Y; Mooney SM; Yeater DB; Mangold LA; Partin AW; Kulkarni P; Getzenberg RH
Prostate; 2012 Jun; 72(9):966-76. PubMed ID: 22025384
[TBL] [Abstract][Full Text] [Related]
4. Cyr61: a potential therapeutic target for prostate cancer.
Lin CM; Liang CZ
Asian J Androl; 2014; 16(5):788-9. PubMed ID: 24759589
[No Abstract] [Full Text] [Related]
5. Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis.
Tang QL; Fan S; Li HG; Chen WL; Shen XM; Yuan XP; Chang SH; Song Y
Oral Oncol; 2011 May; 47(5):365-70. PubMed ID: 21439895
[TBL] [Abstract][Full Text] [Related]
6. CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress.
Shi J; Huo R; Li N; Li H; Zhai T; Li H; Shen B; Ye J; Fu R; Di W
BMC Cancer; 2019 Nov; 19(1):1140. PubMed ID: 31766991
[TBL] [Abstract][Full Text] [Related]
7. Cysteine-rich, angiogenic inducer, 61 expression in patients with ovarian epithelial carcinoma.
Lin Y; Xu T; Tian G; Cui M
J Int Med Res; 2014 Apr; 42(2):300-6. PubMed ID: 24595148
[TBL] [Abstract][Full Text] [Related]
8. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer.
Chen PP; Li WJ; Wang Y; Zhao S; Li DY; Feng LY; Shi XL; Koeffler HP; Tong XJ; Xie D
PLoS One; 2007 Jun; 2(6):e534. PubMed ID: 17579708
[TBL] [Abstract][Full Text] [Related]
9. CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma.
Wei J; Yu G; Shao G; Sun A; Chen M; Yang W; Lin Q
Oncotarget; 2016 May; 7(21):31067-78. PubMed ID: 27105510
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix associated protein CYR61 is linked to prostate cancer development.
D'Antonio KB; Toubaji A; Albadine R; Mondul AM; Platz EA; Netto GJ; Getzenberg RH
J Urol; 2010 Apr; 183(4):1604-10. PubMed ID: 20172544
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells.
Sun ZJ; Wang Y; Cai Z; Chen PP; Tong XJ; Xie D
Br J Cancer; 2008 Nov; 99(10):1656-67. PubMed ID: 18941464
[TBL] [Abstract][Full Text] [Related]
12. The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target.
Whitaker HC; Warren AY; Eeles R; Kote-Jarai Z; Neal DE
Prostate; 2010 Feb; 70(3):333-40. PubMed ID: 19790236
[TBL] [Abstract][Full Text] [Related]
13. Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer.
Pilarsky CP; Schmidt U; Eissrich C; Stade J; Froschermaier SE; Haase M; Faller G; Kirchner TW; Wirth MP
Prostate; 1998 Jul; 36(2):85-91. PubMed ID: 9655260
[TBL] [Abstract][Full Text] [Related]
14. Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.
Sabile AA; Arlt MJ; Muff R; Bode B; Langsam B; Bertz J; Jentzsch T; Puskas GJ; Born W; Fuchs B
J Bone Miner Res; 2012 Jan; 27(1):58-67. PubMed ID: 21976359
[TBL] [Abstract][Full Text] [Related]
15. Cyr61 Expression Pattern and Association with Clinicopathological Factors in Patients with Cervical Cancer.
Mayer S; Gabriel B; Erbes T; Timme-Bronsert S; Jäger M; Rücker G; Kuf F; Bouda J; Bartakova A; Hausen AZ; Stickeler E; Gitsch G; Hirschfeld M
Anticancer Res; 2017 May; 37(5):2451-2456. PubMed ID: 28476813
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma.
Zhou ZQ; Cao WH; Xie JJ; Lin J; Shen ZY; Zhang QY; Shen JH; Xu LY; Li EM
BMC Cancer; 2009 Aug; 9():291. PubMed ID: 19698122
[TBL] [Abstract][Full Text] [Related]
17. Cyr61 is up-regulated in prostate cancer and associated with the p53 gene status.
Lv H; Fan E; Sun S; Ma X; Zhang X; Han DM; Cong YS
J Cell Biochem; 2009 Mar; 106(4):738-44. PubMed ID: 19180570
[TBL] [Abstract][Full Text] [Related]
18. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
[TBL] [Abstract][Full Text] [Related]
19. Blood-based detection of lung cancer using cysteine-rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study.
Ačkar L; Casjens S; Andreas A; Raiko I; Brüning T; Geffken M; Peine S; Kollmeier J; Johnen G; Bartkowiak K; Weber DG; Pantel K
Mol Oncol; 2021 Nov; 15(11):2877-2890. PubMed ID: 34510714
[TBL] [Abstract][Full Text] [Related]
20. Production of Cyr61 protein is modulated by extracellular acidification and PI3K/Akt signaling in prostate carcinoma PC-3 cells.
Lee YJ; Lee DM; Lee SH
Food Chem Toxicol; 2013 Aug; 58():169-76. PubMed ID: 23623839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
